1. Singapore - 11 July 2013 – The eye disease glaucoma leads to blindness and has no symptoms in the early stages, earning it the nickname “silent thief of sight”. Regular eye examinations are essential for early detection and diagnosis of such eye diseases. A new collaboration between A*STAR’s Institute for Infocomm Research (I2R), and Topcon Corporation, Tokyo, Japan, a leading ophthalmic instruments and optometrics instruments manufacturer worldwide could soon make detecting major eye diseases in Singapore an easier task. The ATLANTIA (Advanced Technological Laboratory for A*STAR aNd Topcon’s Innovative Alliance) joint laboratory, located in I2R’s premises in Fusionopolis, will develop advanced technologies that can better detect major eye disorders and diseases such as myopia, glaucoma, and age-related macular degeneration (AMD).
Such common eye ailments leading to visual impairment have a considerable economic and social impact on patients, healthcare industry and the government. Early detection can lead to better management and swifter treatment of such diseases. This could potentially reduce pain and suffering for patients. .
3. Leveraging on the expertise and capabilities of I2R’s Ocular Imaging Programme and Topcon Corporation, the joint laboratory will develop automated intelligent technologies aimed at improving accuracies and reducing the time taken to detect eye diseases and disorders. These technologies will be able to automatically process and analyse eye images captured by ocular imaging equipment, to eventually identify the diseases accordingly.
4. The collaboration will allow for the future screening of glaucoma, myopia and AMD during routine eye checks at hospitals and at optical shops as an added convenience, as the technology can be embedded into eye screening machines.
5. In addition, a cloud based data management system will be co-developed in this joint laboratory to enable better integration of innovative software and hardware technologies to provide more widespread access for doctors, opticians and patients. The ATLANTIA joint laboratory will use Topcon’s Swept-Source OCT (Optical Coherence Tomography), a revolutionary imaging technology that enables eye doctors to view cross-sections of the eye and determine the underlying causes of eye diseases. The joint laboratory will also tap on I2R’s Ocular Imaging Programme’s vast experience and expertise on inter-disciplinary eye-related research using a suite of ocular imaging-based computer-aided diagnosis/screening systems for major eye diseases.
6. “It is a great pleasure to establish a joint laboratory with I2R. For early detection of eye diseases, Topcon is developing the cloud based eye screening and management system. I2R has capabilities in developing the image recognition software from horizontal and cross-sectional ocular images which can be incorporated into our system. We acknowledge I2R’s further potential to make mutual growth for early detection of eye disease. ” said Mr. Yasufumi Fukuma, President of Eye Care Company, Topcon Corporation.
7. “Our eyes are the windows to the world. Early detection of eye diseases such as glaucoma, myopia and age-related macular degeneration can potentially reduce healthcare costs and prevent and reduce pain and suffering for the patients. We are very happy to work with Topcon Corporation to develop a wide spectrum of capabilities to help detect these common eye ailments before they deteriorate and cause loss of sight,” said Dr. Tan Geok Leng, Executive Director, Institute for Infocomm Research (I2R).For more information, please contact:
Journal information1 Source : “Study sheds light on child myopia”. NUS. http://newshub.nus.edu.sg/headlines/0512/myopia_21May12.php
2 Source: SingHealth. http://www.singhealth.com.sg/DoctorsAndHealthcareProfessionals/Medical-News/2012/Pages/age-related-macular-degeneration.aspx
New discoveries predict ability to forecast dementia from single molecule
12.12.2018 | UT Southwestern Medical Center
Pain: Perception and motor impulses arise in the brain independently of one another
12.12.2018 | Technische Universität München
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.
Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...
Scientists at the University of Stuttgart and the Karlsruhe Institute of Technology (KIT) succeed in important further development on the way to quantum Computers.
Quantum computers one day should be able to solve certain computing problems much faster than a classical computer. One of the most promising approaches is...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
12.12.2018 | Health and Medicine
12.12.2018 | Physics and Astronomy
12.12.2018 | Health and Medicine